プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
500 micromol/ ml
500 mikromol/ ml
最終更新: 2012-04-10
使用頻度: 2
品質:
optimark 500 micromol/ml solution for injection in vial
optimark 500 mikromol/ml soluzzjoni għall-injezzjoni f’kunjett
最終更新: 2017-04-26
使用頻度: 1
品質:
optimark 500 micromol/ ml solution for injection in a vial
optimark 500 mikromol/ ml soluzzjoni għall- injezzjoni f’ kunjett
最終更新: 2012-04-10
使用頻度: 2
品質:
optimark 500 micromol/ml solution for injection in vial gadoversetamide
optimark 500 mikromol/ml soluzzjoni għall-injezzjoni f’kunjett gadoversetamide
最終更新: 2017-04-26
使用頻度: 1
品質:
1 ml contains 330.9 mg gadoversetamide, equivalent to 500 micromol.
1 ml fih 330.9 mg ta’ gadoversetamide, ekwivalenti għal 500 mikromol.
最終更新: 2017-04-26
使用頻度: 2
品質:
optimark 500 micromol/ ml solution for injection in a vial gadoversetamide
optimark 500 mikromol/ ml soluzzjoni għall- injezzjoni f’ kunjett gadoversetamide
最終更新: 2012-04-10
使用頻度: 2
品質:
optimark 500 micromol/ml solution for injection in pre-filled syringe
optimark 500 mikromol/ml soluzzjoni għall-injezzjoni f’siringa mimlija għal-lest
最終更新: 2017-04-26
使用頻度: 1
品質:
optimark 500 micromol/ ml solution for injection in a pre-filled syringe
optimark 500 mikromol/ ml soluzzjoni għall- injezzjoni, f’ siringa mimlija għal- lest
最終更新: 2012-04-10
使用頻度: 2
品質:
optimark 500 micromol/ml solution for injection in pre-filled syringe gadoversetamide
optimark 500 mikromol/ml soluzzjoni għall-injezzjoni f’siringa mimlija għal-lest gadoversetamide
最終更新: 2017-04-26
使用頻度: 2
品質:
optimark 500 micromol/ ml solution for injection in a pre-filled syringe gadoversetamide
optimark 500 mikromol/ ml soluzzjoni għall- injezzjoni f’ siringa mimlija għal- lest gadoversetamide
最終更新: 2012-04-10
使用頻度: 4
品質:
optimark 500 micromol/ ml solution for injection in a pre-filled syringe gadoversetamide iv use.
optimark 500 mikromol/ ml soluzzjoni għall- injezzjoni f’ siringa mimlija għal- lest gadoversetamide użu għal ġol- vini.
最終更新: 2012-04-10
使用頻度: 2
品質:
in vitro, glivec inhibits paracetamol o-glucuronidation with ki value of 58.5 micromol/l.
in-vitro, glivec jinibixxi paracetamol o-glucuronidation b’valur ki ta’ 58.5 mikromol/l.
最終更新: 2017-04-26
使用頻度: 1
品質:
a more restricted tyrosine and phenylalanine diet should be implemented in case the plasma tyrosine level is above 500 micromol/ l.
dieta iktar ristretta ta ’ tyrosine u phenylalanine għandha tiġi implimentata fil- każ li l- livell ta ’ tyrosine fil- plażma jkun iktar minn 500 micromol/ l.
最終更新: 2012-04-10
使用頻度: 2
品質:
gadoversetamide has been tested in humans in doses up to 700 micromol/kg (seven times the standard dose).
gadoversetamide kien ittestjat fil-bnedmin f’dożi sa massimu ta’ 700 mikromol/kg (seba’ darbiet iktar mid-doża standard).
最終更新: 2017-04-26
使用頻度: 3
品質:
there was no systematic difference in any of the kinetic parameters as a function of dose level (100 to 700 micromol/kg).
ma kien hemm ebda differenza sistematika fl-ebda wieħed mill-parametri kinetiċi bħala funzjoni tal- livell tad-doża (100 sa 700 mikromol/kg).
最終更新: 2017-04-26
使用頻度: 3
品質:
colestilan was also associated in dose-dependent reduction in serum uric acid, with a mean reduction of 43 micromol/l after one year of treatment.
colestilan ġie assoċjat ukoll ma’ tnaqqis li jiddependi fuq id-doża fil-uric acid fis-serum, bi tnaqqis medju ta’ 43 micromol/l wara sena ta’ kura.
最終更新: 2017-04-26
使用頻度: 1
品質:
in the clinical studies, patients with serum creatinine > 400 micromol/l or > 4.5 mg/dl were excluded.
fl-istudji kliniċi, pazjenti li kellhom krejatinina fis-serum ta’ >400 micromol/l jew >4.5 mg/dl kienu esklużi.
最終更新: 2017-04-26
使用頻度: 1
品質:
警告:見えない HTML フォーマットが含まれています
still, after 72 hours even in patients with severe renal impairment nearly the whole dose is recovered in the urine and in healthy populations up to 500 micromol/kg doses were administered without safety issues.
madankollu, xorta waħda wara 72 siegħa, anke f’pazjenti b’indeboliment serju tal-kliewi, kważi d-doża kollha tkun irkuprata fl-awrina, u f’popolazzjonijiet f’saħħithom ingħataw dożi sa 500 mikromol/kg mingħajr ma kien hemm problemi ta’ sigurtà.
最終更新: 2017-04-26
使用頻度: 3
品質:
the agent should be administered as a bolus peripheral intravenous injection at a dose of 0.2 ml/kg (100 micromol/kg) body weight.
is-sustanza għandha tingħata bħala injezzjoni ġol-vina periferali bolus f’doża ta’ 0.2 ml/kg (100 mikromol/kg) ta’ piż tal-ġisem.
最終更新: 2017-04-26
使用頻度: 3
品質:
gadolinium containing mri contrast agents (gadolinium-based chelates) are designed to act indirectly on the local magnetic environment by altering proton t1 (spin-lattice) and t2 (spin-spin) relaxation times and at the usual concentration of 100 micromol/kg, the t1 shortening predominates, and the t2 shortening is not significant using t1-weighted sequences.
sustanzi tal-kuntrast tal-mri li fihom gadolinium (kelati bbażati fuq gadolinium) huma maħsuba biex jaġixxu indirettament fuq l-ambjent manjetiku lokali billi jibdlu l-ħinijiet tar-rilassament tal-proton t1 (spin-lattice) u t2 (spin-spin) u fil-konċentrazzjoni normali ta’ 100 mikromol/kg, it-tnaqqis ta’ t1 hu predominanti u t-tnaqqis tat-t2 mhuwiex sinifikanti bl-użu ta’ sekwenzi weighted t1.
最終更新: 2017-04-26
使用頻度: 3
品質: